[
  {
    "ts": null,
    "headline": "Polen Global Growth Portfolio Q2 2025 Commentary",
    "summary": "During the quarter, Polen Global Growth Portfolio returned 8.16% gross of fees (7.87% net of fees) compared to 11.53% for the Index. Read more here.",
    "url": "https://finnhub.io/api/news?id=d175bc3623a511df6d3a413812fe88e9b9482ca9237a7d237886ed448b026549",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753135800,
      "headline": "Polen Global Growth Portfolio Q2 2025 Commentary",
      "id": 136028939,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1148772285/image_1148772285.jpg?io=getty-c-w1536",
      "related": "TMO",
      "source": "SeekingAlpha",
      "summary": "During the quarter, Polen Global Growth Portfolio returned 8.16% gross of fees (7.87% net of fees) compared to 11.53% for the Index. Read more here.",
      "url": "https://finnhub.io/api/news?id=d175bc3623a511df6d3a413812fe88e9b9482ca9237a7d237886ed448b026549"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher Scientific Inc. stock falls Monday, underperforms market",
    "summary": "Thermo Fisher Scientific Inc. stock falls Monday, underperforms market",
    "url": "https://finnhub.io/api/news?id=900d81345ab09929653b43d0252e8ba552f05f814c957ec4c5b6e3f9401409b1",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753115640,
      "headline": "Thermo Fisher Scientific Inc. stock falls Monday, underperforms market",
      "id": 136048072,
      "image": "",
      "related": "TMO",
      "source": "MarketWatch",
      "summary": "Thermo Fisher Scientific Inc. stock falls Monday, underperforms market",
      "url": "https://finnhub.io/api/news?id=900d81345ab09929653b43d0252e8ba552f05f814c957ec4c5b6e3f9401409b1"
    }
  },
  {
    "ts": null,
    "headline": "India In Vitro Diagnostics (IVD) Industry Analysis & Forecast (2025-2034) Featuring Roche, Transasia Bio-Medicals, Bio-Rad Labs, BioMerieux, Sysmex, Abbott, Thermo Fisher Scientific, QIAGEN, Quidel, Danaher",
    "summary": "The market's 6.10% CAGR reflects advances in molecular diagnostics, healthcare infrastructure expansion, and personalized medicine. Key trends include companies like Sysmex enhancing local operations and WHO expanding diabetes-related IVDs. Abbott, Qiagen, Quidel, and Danaher lead the market's innovation-driven growth.Dublin, July 21, 2025 (GLOBE NEWSWIRE) -- The \"India In Vitro Diagnostics Market Report and Forecast 2025-2034\" has been added to ResearchAndMarkets.com's offering. The India in vi",
    "url": "https://finnhub.io/api/news?id=c3fe12143e94572101f067ab25576a9d9b1c1c7f6a7dee2a03a6918bd22fd52f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753092120,
      "headline": "India In Vitro Diagnostics (IVD) Industry Analysis & Forecast (2025-2034) Featuring Roche, Transasia Bio-Medicals, Bio-Rad Labs, BioMerieux, Sysmex, Abbott, Thermo Fisher Scientific, QIAGEN, Quidel, Danaher",
      "id": 136024321,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "The market's 6.10% CAGR reflects advances in molecular diagnostics, healthcare infrastructure expansion, and personalized medicine. Key trends include companies like Sysmex enhancing local operations and WHO expanding diabetes-related IVDs. Abbott, Qiagen, Quidel, and Danaher lead the market's innovation-driven growth.Dublin, July 21, 2025 (GLOBE NEWSWIRE) -- The \"India In Vitro Diagnostics Market Report and Forecast 2025-2034\" has been added to ResearchAndMarkets.com's offering. The India in vi",
      "url": "https://finnhub.io/api/news?id=c3fe12143e94572101f067ab25576a9d9b1c1c7f6a7dee2a03a6918bd22fd52f"
    }
  },
  {
    "ts": null,
    "headline": "Mass Spectrometry Company Evaluation Report 2025 | Agilent, Thermo Fisher, and Waters Lead with Robust Portfolios, Strategic Expansions, and Innovation-Driven Growth",
    "summary": "The Mass Spectrometry Companies Quadrant provides an in-depth analysis of the global mass spectrometry market, highlighting key players, technological advancements, and emerging trends. Evaluating over 100 companies, the quadrant identifies the top 14 leaders. The rising pharmaceutical R&D spending, food quality focus, and environmental testing demand are projected to boost the market. The instruments segment, notable for its high-resolution capabilities, is expected to grow significantly from 2",
    "url": "https://finnhub.io/api/news?id=611712117f57c8e895200774a4ab7ac04848a348b9cf9da13ce45403d98dc7d3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753085280,
      "headline": "Mass Spectrometry Company Evaluation Report 2025 | Agilent, Thermo Fisher, and Waters Lead with Robust Portfolios, Strategic Expansions, and Innovation-Driven Growth",
      "id": 136023688,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "The Mass Spectrometry Companies Quadrant provides an in-depth analysis of the global mass spectrometry market, highlighting key players, technological advancements, and emerging trends. Evaluating over 100 companies, the quadrant identifies the top 14 leaders. The rising pharmaceutical R&D spending, food quality focus, and environmental testing demand are projected to boost the market. The instruments segment, notable for its high-resolution capabilities, is expected to grow significantly from 2",
      "url": "https://finnhub.io/api/news?id=611712117f57c8e895200774a4ab7ac04848a348b9cf9da13ce45403d98dc7d3"
    }
  },
  {
    "ts": null,
    "headline": "Cell‑Based Assays Report 2025: Key Market Drivers, Tech Trends & Competitive Landscape to 2030",
    "summary": "The global cell-based assays market is set to grow from USD 17.84 billion in 2025 to USD 27.55 billion by 2030, marking a CAGR of 9.1%. This surge is fueled by the rising demand in drug discovery and increased R&D investments by the pharmaceutical and biotech industries. The prevalence of cancer is boosting the need for advanced therapies, while the growth of cell-based assays applications in chronic diseases and personalized medicine further propels market expansion. In 2024, the drug discovery",
    "url": "https://finnhub.io/api/news?id=d8a95852b16344fcade06d2d51ea3d5d2037e31d9300e32eeacdf3e003a7a937",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753084980,
      "headline": "Cell‑Based Assays Report 2025: Key Market Drivers, Tech Trends & Competitive Landscape to 2030",
      "id": 136023689,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "The global cell-based assays market is set to grow from USD 17.84 billion in 2025 to USD 27.55 billion by 2030, marking a CAGR of 9.1%. This surge is fueled by the rising demand in drug discovery and increased R&D investments by the pharmaceutical and biotech industries. The prevalence of cancer is boosting the need for advanced therapies, while the growth of cell-based assays applications in chronic diseases and personalized medicine further propels market expansion. In 2024, the drug discovery",
      "url": "https://finnhub.io/api/news?id=d8a95852b16344fcade06d2d51ea3d5d2037e31d9300e32eeacdf3e003a7a937"
    }
  }
]